Long-term debt · 2019–2021
Biontech long-term debt
$194M−31.4% · FY2021
Biontech (BNTX) reported $194M in long-term debt for fiscal 2021, −31.4% year on year.
Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2021 compound annual growth +58.5%
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Long-term debt at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biontech long-term debt |url=https://companiesranked.com/en/company/biontech/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biontech long-term debt. CompaniesRanked. https://companiesranked.com/en/company/biontech/long-term-debtBibTeX
@misc{companiesranked-en-company-biontech-long-term-debt-2026,
author = {{CompaniesRanked}},
title = {{Biontech long-term debt}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biontech/long-term-debt}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.